Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Laparoscopic Total Gastrectomy with D2 Lymphadenectomy for Advanced Gastric Cancer
    Ju-Hee Lee
    Sang-Hoon Ahn
    Do Joong Park
    Hyung-Ho Kim
    Hyuk-Joon Lee
    Han-Kwang Yang
    World Journal of Surgery, 2012, 36 : 2394 - 2399
  • [22] Laparoscopic Total Gastrectomy with D2 Lymphadenectomy for Advanced Gastric Cancer
    Lee, Ju-Hee
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hyuk-Joon
    Yang, Han-Kwang
    WORLD JOURNAL OF SURGERY, 2012, 36 (10) : 2394 - 2399
  • [23] Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
    Jin, Ying
    Qiu, Miao-zhen
    Wang, De-shen
    Zhang, Dong-sheng
    Ren, Chao
    Bai, Long
    Luo, Hui-yan
    Wang, Zhi-qiang
    Wang, Feng-hua
    Li, Yu-hong
    Xu, Rui-hua
    PLOS ONE, 2013, 8 (01):
  • [24] Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
    Zheng, Xiaohao
    Wu, Yunzi
    Zheng, Li
    Xue, Liyan
    Jiang, Zhichao
    Wang, Chenfeng
    Xie, Yibin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Adjuvant chemotherapy after D2 gastrectomy for gastric cancer
    Takaki Yoshikawa
    Mitsuru Sasako
    Nature Reviews Clinical Oncology, 2012, 9 : 192 - 194
  • [26] Adjuvant therapy for gastric cancer after D2 gastrectomy
    Nishida, Toshirou
    LANCET, 2012, 379 (9813): : 291 - 292
  • [27] Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study
    Deng, Zi-Jian
    Lu, Jun
    Nie, Run-Cong
    Fang, Jia-Ming
    Chen, Xi-Jie
    Liu, Jun-Jie
    Li, Xian-Zhe
    Chen, Ying-Bo
    Huang, Chang-Ming
    Lian, Lei
    Peng, Jun-Sheng
    Chen, Shi
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (13) : 8214 - 8224
  • [28] Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?-reply letter
    Sakaguchi, Masazumi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (05) : 2701 - 2702
  • [29] Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial
    Liu, Xin
    Yan, Yongjia
    Lu, Li
    Liu, Yang
    Ma, Jun
    Wang, Xi
    Wang, Daohan
    Liu, Bang
    Liu, Zhuo
    Zhou, Xueying
    Cui, He
    Zhao, Zhicheng
    Li, Chuan
    Liu, Jian
    Li, Weidong
    Huang, Qing-Xing
    Zhao, Qun
    Liu, Tong
    Fu, Weihua
    CANCER MEDICINE, 2024, 13 (11):
  • [30] Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
    Cho, Jang Ho
    Lim, Jae Yun
    Cho, Jae Yong
    PLOS ONE, 2017, 12 (10):